India Globalization Capital, Inc. (NYSE American:IGC) (the “Company”) provides IGC operations update on Stock Day Podcast with Everett Jolly.
Ram Mukunda, CEO of India Globalization Capital, Inc., Joins Everett Jolly
IGC has a legacy business in infrastructure focused primarily in India, Malaysia and Hong Kong. More recently the company has expanded into the Cannabis Pharmacy business, which will reach the United States and Canada.
“The diversification in IGC both geographically and by industry makes it an interesting investment,” said Jolly. “The cannabis industry is rapidly growing in the United States; the Company’s decision to direct their attention to one specific area of study, Alzheimer’s, will allow parallel penetration into the industry.”
Mukunda commented, “We are preparing to release our first product, Hyalolex, through dispensaries in the next several weeks. In parallel we are also pursuing a traditional FDA path that is in its pre-clinical phase. Our product is the result of many years of research and I look forward to the positive effects it will have on Alzheimer’s patients.”